Skip to main content

Table 2 Pooled prevalence of severity signs among reported severe vivax malaria patients (77 studies)

From: Severe vivax malaria: a systematic review and meta-analysis of clinical studies since 1900

Complication

Total vivax

Total patients with severity sign

Pooled prevalence, %

95% CI, %

Death

46411

353

0.3

0.1–0.4

Cerebral malaria

45845

532

0.8

0.5–1.1

Multiple convulsions

46386

88

0.2

0–0.5

Renal dysfunction

46341

244

1.1

0.3–1.9

Respiratory dysfunction

46411

144

0.3

0.1–0.5

Hepatic dysfunction

46536

727

4.2

3.2–5.2

Abnormal bleeding/DIC

46346

206

0.6

0.2–1

Haemoglobinuria

46411

93

0.1

0–0.4

Hypoglycaemia

46381

44

1.8

0.9–2.7

Metabolic acidosis

46341

138

1

0–2.3

Circulatory collapse/Shock

46411

67

5.1

2.5–7.7

Severe anaemia

46411

2276

4

2.9–5.1

Severe thrombocytopenia

45775

888

8.6

5.4–11.8